Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Voriconazol-resistentie en mortaliteit bij invasieve aspergillose
jan 2019 | Schimmelinfecties